Polar Asset Management Partners Inc. 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 06:53 am Purchase | 2023-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Polar Asset Management Partners Inc. | 1,193 6.100% | 978 (+454.88%) | Filing |
| 2023-02-09 6:29 pm Sale | 2022-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Polar Asset Management Partners Inc. | 215 10.000% | -816 (-79.15%) | Filing |
| 2022-02-08 11:07 am Purchase | 2021-12-31 | 13G | CALIDI BIOTHERAPEUTICS, INC. C CLDI | Polar Asset Management Partners Inc. | 1,031 8.610% | 1,031 (New Position) | Filing |